AIM AND SCOPE
Journal of Clinical Trials and Vaccine research (JCTV) aims at the rapid publication of high-quality results in Clinical Trials and Vaccine research while maintaining a rigorous peer-review process. All accepted papers will be appearing online immediately.
JCTV encourages submission of manuscripts related to (but not limited to) Bacterial Biothreat Agents, Cholera, Dengue, DNA Vaccines, Infectious Diseases, Influenza, Malaria Mycobacterium tuberculosis, Plague, Rabies,Smallpox Publishing Areas:
- DNA Vaccines
- Infectious Diseases
- Influenza
- Malaria
- Mycobacterium tuberculosis
- Plague
- Rabies
- Smallpox
- Typhoid Fever
- Vaccine Adjuvants
- Vaccine Immunology
- Viral Vectors
Publication of article types:
Original research articles: Describes original research within the scope of the journal.
Case reports: Reports of clinical presentations describing a diagnostic or therapeutic dilemma followed by evaluative studies
Editorial comments: Introduce current research and comment on major advances and developments in the field.
Methodology: Present a new experimental method, test or procedure. The methods described may be completely new or a better version of already existing one. The method should demonstrate all the possible tests and results.
Rapid communications: Short papers presenting highly significant and original material.
Review articles: To review the progression of a research in the field and make suggestions for future work includes authoritative, comprehensive, descriptions of any subject within the scope of Clinical Trials and Vaccine research journal.
Letters to the editor: Letter consisting of comments directly on publications of journal which are already published or introduces a specific issue of a general interest.
As Journal of Clinical Trials and Vaccine research follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online and JCTV will be kept up to date with latest advances in the field of Clinical Trials and Vaccine research. All published articles will be assigned with unique Digital Objective Identifier provided by Cross Ref.
